Skip to main content

Table 2 KEGG pathway enrichment for the genes in the coexpression modules

From: Investigation of the gene co-expression network and hub genes associated with acute mountain sickness

ModuleTermCount%PValue
M1hsa03010:Ribosome552.985.82E-18
hsa04144:Endocytosis532.872.69E-06
hsa05016:Huntington’s disease482.601.8E-07
hsa05012:Parkinson’s disease472.541.18E-11
hsa00190:Oxidative phosphorylation442.386.04E-11
M2hsa05016:Huntington’s disease313.786.94E-08
hsa03010:Ribosome293.543.32E-10
hsa05012:Parkinson’s disease273.291.97E-08
hsa05010:Alzheimer’s disease263.172.25E-06
hsa00190:Oxidative phosphorylation242.933.91E-07
M3hsa04145:Phagosome175.472.48E-07
hsa05168:Herpes simplex infection165.141.63E-05
hsa04144:Endocytosis144.500.003325
hsa04142:Lysosome134.181.79E-05
hsa04141:Protein processing in endoplasmic reticulum134.180.000453
M4hsa04380:Osteoclast differentiation196.293.23E-10
hsa05152:Tuberculosis165.306.22E-06
hsa04145:Phagosome154.974.18E-06
hsa05140:Leishmaniasis134.303.15E-08
hsa05164:Influenza A134.300.00039
M6hsa04010:MAPK signaling pathway74.270.027535
hsa03040:Spliceosome63.660.007182
hsa05164:Influenza A63.660.021085
hsa04015:Rap1 signaling pathway63.660.04254
hsa00310:Lysine degradation53.050.001245
M7hsa05200:Pathways in cancer117.010.00439
hsa05152:Tuberculosis95.730.000293
hsa04071:Sphingolipid signaling pathway74.460.001042
hsa05161:Hepatitis B74.460.002742
hsa04650:Natural killer cell mediated cytotoxicity63.820.006497
M8hsa05162:Measles138.335.71E-09
hsa05164:Influenza A127.691.01E-06
hsa05168:Herpes simplex infection117.051.21E-05
hsa05160:Hepatitis C106.416.11E-06
hsa04978:Mineral absorption63.857.03E-05